Sladjana Filipovic
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Lesions and Carcinomas, Estrogen and related hormone effects
Most-Cited Works
- → Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial(2017)580 cited
- Stressful life events and breast cancer risk: a hospital-based case-control study.(2015)
- Young age and pathological features predict breast cancer outcome - report from a dual Institution experience in Serbia.(2016)
- Mantle cell lymphoma-current literature overview.(2014)
- Clinical benefit of cetuximab and prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer: a single institution analysis.(2014)
- → Significance of serum tumor markers monitoring in carcinomas of unknown primary site(2010)2 cited
- → Assessment of axillary lymph nodes involvement in patients with breast cancer depending on the tumor size and its histological and nuclear grades(2012)2 cited
- → Risk factors for nipple involvement in breast cancer patients(2005)2 cited
- → Biomarkers in breast cancer(2006)2 cited
- Ten years of using adjuvant trastuzumab in breast cancer in Serbia - Single institution experience.(2019)